NASDAQ:PDSB

Pds Biotechnology Stock Forecast

etoro logo Buy PDSB
*Your capital is at risk
$1.02
-0.200 (-16.39%)
At Close: Jun 05, 2026
AI Analysis AI Analysis of PDSB AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add PDSB to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Volatile ride for PDS Biotechnology Corp. stock price on Friday moving between $1.01 and $1.25
(Updated on Jun 05, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jun 05, 2026

The PDS Biotechnology Corp. stock price fell by -16.39% on the last day (Friday, 5th Jun 2026) from $1.22 to $1.02. During the last trading day the stock fluctuated 23.75% from a day low at $1.01 to a day high of $1.25. The price has risen in 6 of the last 10 days but is still down by -12.07% for this period. Volume has increased on the last day by 397 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $1.61 million.

Given the current short-term trend, the stock is expected to rise 70.12% during the next 3 months and, with a 90% probability hold a price between $1.74 and $2.70 at the end of this 3-month period.

PDSB Signals & Forecast

There are few to no technical positive signals at the moment. The PDS Biotechnology Corp. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.11 and $1.13. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, May 14, 2026, and so far it has fallen -28.67%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for PDS Biotechnology Corp. stock

PDS Biotechnology Corp. finds support from accumulated volume at $1.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.240 between high and low, or 23.75%. For the last week, the stock has had daily average volatility of 14.19%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PDSB) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect PDS Biotechnology Corp. to open at $1.09, and during the day (based on 14 day Average True Range), to move between $0.95 and $1.09, which gives a possible trading interval of +/-$0.148 (+/-15.68%) up or down from last closing price. If PDS Biotechnology Corp. takes out the full calculated possible swing range there will be an estimated 15.68% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.00 (1.96%) than the resistance at $1.07 (4.90%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is PDS Biotechnology Corp. stock A Buy?

The PDS Biotechnology Corp. stock holds several negative signals and despite the positive trend, we believe PDS Biotechnology Corp. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -3.267 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $1.09 ( 7.19%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

PDSB Performance

Trading levels for PDSB

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.33 30.71%
R2 1.24 21.72%
R1 1.18 16.17%
Price 1.02
S1 1.00 -1.80%
S2 0.95 -7.35%
S3 0.85 -16.33%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.10 7.84%
R2 1.08 5.88%
R1 1.07 4.90%
Price 1.02
S1 1.00 -1.96%
S2 0.93 -9.01%
S3 0.92 -10.00%

FAQ

What is the symbol for PDS Biotechnology Corp. Stock and on which exchange is it traded?
The symbol for PDS Biotechnology Corp. is PDSB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell PDS Biotechnology Corp. Stock?
The PDS Biotechnology Corp. stock holds several negative signals and despite the positive trend, we believe PDS Biotechnology Corp. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

How to buy PDS Biotechnology Corp. Stock?
PDS Biotechnology Corp. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy PDS Biotechnology Corp. Stock.

What's the current price of PDS Biotechnology Corp. Stock?
As of the end of day on the Jun 05, 2026, the price of an PDS Biotechnology Corp. (PDSB) share was $1.02.

What is the 52-week high and low for PDS Biotechnology Corp. Stock?
The 52-week high for PDS Biotechnology Corp. Stock is $1.92 and the 52-week low is $0.520.

What is the market capitalization of PDS Biotechnology Corp. Stock?
As of the Jun 05, 2026, the market capitalization of PDS Biotechnology Corp. is 56.932M.

When is the next earnings date for PDS Biotechnology Corp.?
The upcoming earnings date for PDS Biotechnology Corp. is Aug 12, 2026.
Click to get the best stock tips daily for free!
ABOUT PDS BIOTECHNOLOGY CORP.
PDS Biotechnology
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclini...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
4.09% May 06
GLBE
$31.61
1.65% May 05
SAP
$172.39
7.18% May 05
FIZZ
$34.11
7.04% May 01
ADBE
$243.57
3.23% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE